Overcoming Therapeutic Challenges for Pancreatic Ductal Adenocarcinoma with xCT Inhibitors

被引：1
|
作者：
Vucetic, Milica [1 ]
Daher, Boutaina [1 ]
Cassim, Shamir [1 ]
Parks, Scott [2 ,3 ]
Pouyssegur, Jacques [1 ,4 ]
机构：
[1] Ctr Sci Monaco CSM, Dept Med Biol, Beaulieu Sur Mer, MC, Monaco
[2] Trev & Joyce Deeley Res Ctr, BC Canc, Victoria, BC, Canada
[3] Univ Victoria, Genome British Columbia Prote Ctr, Victoria, BC, Canada
[4] Univ Cote dAzur IRCAN, CNRS, Ctr A Lacassagne, INSERM, Nice, France
来源：
FERROPTOSIS: MECHANISM AND DISEASES | 2021年 / 1301卷
关键词：
X(C)(-) TRANSPORTER ACTIVITY; CANCER-CELLS; CYSTINE/GLUTAMATE ANTIPORTER; CALRETICULIN EXPOSURE; IMPROVES SURVIVAL; OXIDATIVE STRESS; CYSTINE; GEMCITABINE; GLUTATHIONE; FERROPTOSIS;
D O I：
10.1007/978-3-030-62026-4_2
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：7 / 24
页数：18
相关论文
共 50 条
  • [31] Pathology of pancreatic ductal adenocarcinoma:Facts,challenges and future developments
    Irene Esposito
    Bj?rn Konukiewitz
    Anna Melissa Schlitter
    Günter Kl?ppel
    World Journal of Gastroenterology, 2014, (38) : 13833 - 13841
  • [32] The Challenges of Improving Survival Following Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma
    Shukla, Parul J.
    ANNALS OF SURGERY, 2011, 254 (02) : 385 - 386
  • [33] The evolution into personalized therapies in pancreatic ductal adenocarcinoma: challenges and opportunities
    Tesfaye, Anteneh A.
    Kamgar, Mandana
    Azmi, Asfar
    Philip, Philip A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (02) : 131 - 148
  • [34] Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments
    Esposito, Irene
    Konukiewitz, Bjoern
    Schlitter, Anna Melissa
    Kloeppel, Guenter
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (38) : 13833 - 13841
  • [35] Exploring therapeutic strategies against pancreatic ductal adenocarcinoma (PDAC).
    Liaki, Vasiliki
    CANCER RESEARCH, 2021, 81 (22) : 58 - 59
  • [36] MicroRNAs: Novel Diagnostic and Therapeutic Tools for Pancreatic Ductal Adenocarcinoma?
    Mardin, Wolf Arif
    Mees, Soeren Torge
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (11) : 3183 - 3189
  • [37] Metabolic signatures in pancreatic ductal adenocarcinoma: diagnostic and therapeutic implications
    Gong Ruining
    Hu Yonglu
    Yu Qian
    Fang Lin
    Ren He
    胰腺病学杂志（英文）, 2023, 06 (04)
  • [38] New therapeutic Target Structures for Pancreatic ductal Adenocarcinoma Patients?
    Hofmann-Assmus, Marion
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2019, 57 (09): : 1029 - 1029
  • [39] Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma
    Abudureyimu Tuerhong
    Jin Xu
    Si Shi
    Zhen Tan
    Qingcai Meng
    Jie Hua
    Jiang Liu
    Bo Zhang
    Wei Wang
    Xianjun Yu
    Chen Liang
    Cellular and Molecular Life Sciences, 2021, 78 : 5505 - 5526
  • [40] Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma
    Fischietti, Mariafausta
    Eckerdt, Frank
    Blyth, Gavin T.
    Arslan, Ahmet D.
    Mati, William M.
    Oku, Chidera, V
    Perez, Ricardo E.
    Lee-Chang, Catalina
    Kosciuczuk, Ewa M.
    Saleiro, Diana
    Beauchamp, Elspeth M.
    Lesniak, Maciej S.
    Verzella, Daniela
    Sun, Leyu
    Fish, Eleanor N.
    Yang, Guang-Yu
    Qiang, Wenan
    Platanias, Leonidas C.
    ONCOGENE, 2021, 40 (18) : 3273 - 3286
12345